Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_04774 |
| Species: | Homo sapiens |
| Position : | chr4:100078375-100078940 |
| Year: | 2010 |
| Title: | Identification of a FOXA-dependent enhancer of human alcohol dehydrogenase 4 (ADH4) |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Normal |
| PMID: | 20363298 |
| Tissue: | liver |
| Tissue Ontology ID: | UBERON:0002107 |
| Cell Source: | H1299 negative-control cell line |
| CVCL ID: | CVCL_0060 |
| Cell Type: | malignant cell |
| Cell Ontology ID: | CL:0001064 |
| Experiment Type: | Reporter-based enhancer mapping; TF-binding and site-mutation validation |
| Low Throughput Method: | Luciferase reporter assay; EMSA; antibody supershift; site-directed TF-binding-site mutagenesis; haplotype/variant reporter analysis |
| Target gene : | ADH4 |
| TF name : | FOXA2 |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|---|---|---|
| FOXA2 | FOXA1 transcription factor network | pid | 45 |
| FOXA2 | FOXA2 and FOXA3 transcription factor networks | pid | 45 |
| FOXA2 | Hedgehog signaling events mediated by Gli proteins | pid | 49 |
| FOXA2 | Regulation of gene expression in beta cells | reactome | 17 |
| FOXA2 | Maturity onset diabetes of the young | kegg | 25 |
| FOXA2 | Hs_Endoderm_Differentiation_WP2853_88152 | wikipathways | 62 |
| FOXA2 | Hs_Dopaminergic_Neurogenesis_WP2855_87239 | wikipathways | 19 |
| FOXA2 | Hs_Heart_Development_WP1591_90186 | wikipathways | 28 |
| FOXA2 | Hs_Ectoderm_Differentiation_WP2858_89329 | wikipathways | 56 |